171 related articles for article (PubMed ID: 12496253)
41. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
[TBL] [Abstract][Full Text] [Related]
42. The Arg-4 mutant factor IX Strasbourg 2 shows a delayed activation by factor XIa.
de la Salle C; Charmantier JL; Ravanat C; Ohlmann P; Hartmann ML; Schuhler S; Bischoff R; Ebel C; Roecklin D; Balland A
Nouv Rev Fr Hematol (1978); 1993; 35(5):473-80. PubMed ID: 8295821
[TBL] [Abstract][Full Text] [Related]
43. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
44. Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells.
Lin SW; Smith KJ; Welsch D; Stafford DW
J Biol Chem; 1990 Jan; 265(1):144-50. PubMed ID: 2294100
[TBL] [Abstract][Full Text] [Related]
45. Structural determinants of the factor IX molecule mediating interaction with the endothelial cell binding site are distinct from those involved in phospholipid binding.
Ryan J; Wolitzky B; Heimer E; Lambrose T; Felix A; Tam JP; Huang LH; Nawroth P; Wilner G; Kisiel W
J Biol Chem; 1989 Dec; 264(34):20283-7. PubMed ID: 2555350
[TBL] [Abstract][Full Text] [Related]
46. Studies on immunological assay of vitamin-K dependent factors. III. A double monoclonal immunoradiometric assay for factor IX antigen.
Mikami S; O'Brien DP; Mellars G; Goodall AH; Tuddenham EG
Br J Haematol; 1986 Mar; 62(3):513-24. PubMed ID: 3485443
[TBL] [Abstract][Full Text] [Related]
47. Update on the physiology and pathology of factor IX activation by factor XIa.
Smith SB; Gailani D
Expert Rev Hematol; 2008 Oct; 1(1):87-98. PubMed ID: 19714257
[TBL] [Abstract][Full Text] [Related]
48. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
49. Protein engineering of the hydrophobic domain of human factor IX.
Hughes PE; Handford PA; Austen DE; Brownlee GG
Protein Eng; 1994 Sep; 7(9):1121-7. PubMed ID: 7831283
[TBL] [Abstract][Full Text] [Related]
50. Substrate-dependent modulation of the mechanism of factor XIa inhibition.
Pedicord DL; Seiffert D; Blat Y
Biochemistry; 2004 Sep; 43(37):11883-8. PubMed ID: 15362874
[TBL] [Abstract][Full Text] [Related]
51. Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa.
Bar Barroeta A; van Galen J; Stroo I; Marquart JA; Meijer AB; Meijers JCM
J Thromb Haemost; 2019 Dec; 17(12):2047-2055. PubMed ID: 31519061
[TBL] [Abstract][Full Text] [Related]
52. Localization of a metal-dependent epitope to the amino terminal residues 33-40 of human factor IX.
Cheung WF; Wolberg AS; Stafford DW; Smith KJ
Thromb Res; 1995 Dec; 80(5):419-27. PubMed ID: 8588203
[TBL] [Abstract][Full Text] [Related]
53. Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX.
Walsh PN; Bradford H; Sinha D; Piperno JR; Tuszynski GP
J Clin Invest; 1984 May; 73(5):1392-9. PubMed ID: 6609171
[TBL] [Abstract][Full Text] [Related]
54. In vitro mutagenesis study of two critical glutamic acids in the calcium binding loop of the factor IX heavy chain.
Hamaguchi N; Stafford D
Thromb Haemost; 1994 Dec; 72(6):856-61. PubMed ID: 7740454
[TBL] [Abstract][Full Text] [Related]
55. Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.
Baglia FA; Sinha D; Walsh PN
Blood; 1989 Jul; 74(1):244-51. PubMed ID: 2665835
[TBL] [Abstract][Full Text] [Related]
56. Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.
Marcinkiewicz MM; Sinha D; Walsh PN
J Biol Chem; 2012 Feb; 287(9):6187-95. PubMed ID: 22207756
[TBL] [Abstract][Full Text] [Related]
57. Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.
Toby GG; Liu T; Buyue Y; Zhang X; Bitonti AJ; Pierce GF; Sommer JM; Jiang H; Peters RT
PLoS One; 2016; 11(2):e0148255. PubMed ID: 26840952
[TBL] [Abstract][Full Text] [Related]
58. Characterization of a factor IX variant with a glycine207 to glutamic acid mutation.
Lin SW; Lin CN; Hamaguchi N; Smith KJ; Shen MC
Blood; 1994 Sep; 84(6):1866-73. PubMed ID: 7915915
[TBL] [Abstract][Full Text] [Related]
59. An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX.
Persson KE; Knobe KE; Stenflo J
Biochem Biophys Res Commun; 2001 Sep; 286(5):1039-44. PubMed ID: 11527405
[TBL] [Abstract][Full Text] [Related]
60. Protease nexin II interactions with coagulation factor XIa are contained within the Kunitz protease inhibitor domain of protease nexin II and the factor XIa catalytic domain.
Badellino KO; Walsh PN
Biochemistry; 2000 Apr; 39(16):4769-77. PubMed ID: 10769134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
